• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Malaysia·Healthcare·5225.KL
Share

IHH Healthcare Berhad Stocks

MYR 8.01Last Updated 22.09.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

MYR 16.56B

MYR 8.01
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Good growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

IHH Healthcare Berhad, established in Kuala Lumpur, Malaysia, in 2010, functions as a global investment holding company renowned for its comprehensive healthcare services. Its expansive operational footprint stretches across Malaysia, Singapore, Turkey, India, China, Japan, Europe, and other international markets. The company delivers a full spectrum of patient care, starting with primary services like routine check-ups, vaccinations, and treatment for common illnesses, and progressing to secondary care encompassing specialist consultations, minor surgeries, and emergency medical attention. It further provides advanced tertiary care, which includes specialized consultations, complex medical treatments, and inpatient services, alongside highly specialized quaternary care, featuring organ transplantation, neurosurgery, intricate cardiac procedures, and reconstructive plastic surgery. Beyond direct patient treatment, IHH Healthcare provides a wide array of supporting and operational services. These include advanced diagnostics, analytical laboratory testing, therapeutic radiology, and integrated rehabilitation, as well as advanced molecular diagnostics. The company is also a significant player in medical education, actively training nurses, doctors, and allied healthcare professionals. Its diverse operations extend to administrative, management, and consultancy services, various emergency and home care offerings (including orthopedic and ambulatory care), and the development of healthcare information systems and technology solutions. Furthermore, IHH Healthcare manages real estate investment trusts, operates specialized centers such as dialysis and treasury facilities, and establishes educational institutions for medical learning and research. It oversees the entire lifecycle of healthcare infrastructure, from developing and constructing facilities to their supervision, management, and leasing. Complementary services like hospital catering, laundry, and cleaning, alongside the import and wholesale of pharmaceuticals and medical materials, are also integral to its vast business portfolio. The company additionally engages in property letting and provides software system integration and application management services.

Company Valuation

Slightly overvalued
3/7

Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBI

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of 5225.KL is 10.3 and suggests 35.4% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

23.09.2026 10:56

FT: The U.S. Backed Chelsea's Former Co-Owner in His Battle with Carlyle Over Lukoil Assets

23.09.2026 10:45

Hawkish Easing: Why BofA Is Betting on Forward Contracts in Kazakhstan

23.09.2026 10:37

Top Stories This Morning: OpenAI and Anthropic Have Made Their AI Models More Affordable; Qualcomm Unveiled a New Chip

23.09.2026 09:00

Apple is developing a new type of device, according to Bloomberg. What is known about the gadget?

23.09.2026 07:30

In the U.S., a second IPO has been canceled in less than a week. Why is this a cause for concern?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026